AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitara-M 100/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sitara-M 100/1000 Tablet ER

Diabex Duo 100/1000 Extended-Release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo 100/1000 ER may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; proper recognition and management of low blood sugar are essential. This medication isn't suitable for all patients. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to decrease blood glucose. Your doctor will monitor renal function and blood sugar levels throughout your treatment.

Primary Ingredients of Sitara-M 100/1000 Tablet ER

The provided text is "undefined," so there is nothing to rephrase.

Uses of Sitara-M 100/1000 Tablet ER

Managing type 2 diabetes

Major Benefits of Sitara-M 100/1000 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitara-M 100/1000 Tablet ER whole; avoid chewing, crushing, or fracturing. Administer with a meal.

Common Side effects of Sitara-M 100/1000 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitara-M 100/1000 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sitara-M 100/1000 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Sitara-M 100/1000 Tablet ER works:

Sitara-M 100/1000 Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and diminishes hepatic glucose production. Metformin, a biguanide, reduces liver glucose output, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Sitara-M 100/1000 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sitara-M 100/1000 tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitara-M 100/1000 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitara-M 100/1000 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitara-M 100/1000 Tablet ER. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The extended-release Sitara-M 100/1000 Tablet may pose unacceptable risks for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Sitara-M 100/1000 Tablet ER :

Should you forget a dose of Sitara-M 100/1000 Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitara-M 100/1000 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitara-M 100/1000 Tablet ER

Sitara-M 100/1000 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitara-M 100/1000 Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia and neurological issues, including numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitara-M 100/1000 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitara-M 100/1000 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitara-M 100/1000 ER tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitara-M 100/1000 Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitara-M 100/1000 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitara-M 100/1000 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitara-M 100/1000 Tablet ER is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitara-M 100/1000 Tablet ER and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitara-M 100/1000 Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitara-M 100/1000 Tablet ER use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues (including tingling, numbness in extremities, weakness, and balance problems), urinary difficulties, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitara-M 100/1000 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitara-M 100/1000 Tablet ER may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitara-M 100/1000 Tablet ER components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitara-M 100/1000 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitara-M 100/1000 Tablet ER can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitara-M 100/1000 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitara-M 100/1000 Tablet ...
141
MRP 164
13% off